Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,005 | 8,326 | 6,886 | 11,075 | 14,040 |
| Receivables | N/A | N/A | 3,702 | 133 | N/A |
| TOTAL | $7,478 | $11,156 | $13,884 | $12,786 | $15,496 |
| Non-Current Assets | |||||
| PPE Net | 16 | 18 | 21 | 24 | 23 |
| Other Non-Current Assets | 1,264 | 334 | 334 | 334 | 334 |
| TOTAL | $1,280 | $352 | $355 | $358 | $358 |
| Total Assets | $8,757 | $11,508 | $14,239 | $13,145 | $15,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,981 | 1,462 | 893 | 1,058 | 946 |
| Accrued Expenses | 225 | 901 | 761 | 535 | 520 |
| TOTAL | $2,594 | $2,407 | $1,831 | $1,902 | $1,905 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,594 | $2,407 | $1,831 | $1,902 | $1,905 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 28 | 27 | 25 | 24 |
| Retained earnings | -35,442 | -32,188 | -28,373 | -24,560 | -20,946 |
| TOTAL | $6,163 | $9,100 | $12,408 | $11,243 | $13,948 |
| Total Liabilities And Equity | $8,757 | $11,508 | $14,239 | $13,145 | $15,853 |